ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1292

Performance of 18fluoride Sodium Positron Emission Tomography with Computed Tomography to Assess Inflammatory and Structural Sacroiliitis Respectively on Magnetic Resonance Imaging and Computed Tomography in Axial Spondyloarthritis

Marie Raynal1, ouichka remy2, Julian Melchior1, Isabelle Chary-Valckenaere3, Willy Ngueyon Sime4, Walter P. Maksymowych5, Robert G. Lambert6 and Damien Loeuille3, 1Rheumatology, CHRU Nancy, Nancy, France, 2rheumatology, CHRU Nancy, Vandoeuvre les Nancy, France, 3Rheumatology, CHRU Nancy, Vandoeuvre les Nancy, France, 4University of Lorraine, Nancy, France, 5Medicine, University of Alberta, Edmonton, AB, Canada, 6Radiology, University of Alberta, Edmonton, AB, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: axial spondyloarthritis, Computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Imaging of Rheumatic Diseases - Poster II: XR/CT/PET/MRI

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: to assess increased SIJ uptakes on 18-FNa (an osteoblastic tracer) PET/CT according to a qualitative and quantitative approach and to compare with MRI SIJ assessments for inflammation and with CT-scan for structural damage in a population of 23 patients with SpA (IDRCB: 2012-A00568-35).

Methods: This single-center prospective study included 23 patients with active SpA according to ASAS and/or modified mNY criteria (males 43.5%, HLA-B27 30%, years 44, symptom duration 7.7 years, median CRP 8mg/L, median BASDAI 6.1). All patients had a pelvic AP-view radiograph, MRI of the SIJ and 18-FNa PET/CT examinations during the same month. For MRI, SIJ were assessed for the presence/absence of inflammation according to ASAS criteria and were quantitatively assessed according to SPARCC method for scoring inflammation. CT-scans were read by three readers blinded to MRI images. Structural lesions were scored in consecutive slices in SIJ quadrants (erosion, sclerosis) or SIJ halves (ankylosis) on a dichotomous basis (present/absent) using the same anatomical principles for defining SIJ quadrants as developed for the SPARCC MRI SIJ inflammation and structural scores. On the 18-FNa PET, SIJ were scored blinded to MRI and CT images by two nuclear physicians according to a slice by slice approach performed from the anterior to the posterior part of the joint. A positive PET was defined when unilateral (sacral or iliac part) uptake was observed on 2 consecutive slices or when bilateral uptake was depicted on a single slice. As for SPARCC MRI methods, quantitative assessment on 18-FNa PET was performed according to SIJ quadrants for six consecutive slices through the cartilaginous region of the joint (PET-activity score). The Standardized Maximal Uptake Value (SUV-max) was measured for each SIJ, corresponding to the highest uptake value of the SIJ.

Results: 7 patients had radiographic sacroiliitis, 9 had inflammatory sacroiliitis on MRI (mean SPARCC 7.65). On CT-scan, inter-reader reliabilities for ankylosis, erosion and sclerosis were excellent to mild (ICC=0.95; ICC=0.81; ICC=0.39) respectively. The concordance between the two readers for a positive PET was good (73.9%) as well as the inter-reader reliabilities for the PET-activity score (ICC= 0.69 (95%CI: 0.40 to 0.86)). 18 patients had a positive PET with a mean PET-activity score of 15.7 (± 14). The mean SUV-max for a positive PET was 1.91 versus 1.27 for a negative one. According to a binary approach, a positive PET did not correlate to a positive MRI (ASAS criteria) or to a structural sacroiliitis on CT-scan. The PET-activity score (r=0.57, p=0.005) and SUV-max (r= 0.02, p=0.046) correlated with the SPARCC inflammation score but not with erosion, ankylosis and both ankylosis-erosions scores on CT-scan (ICC=-0.04; p=0.85), (ICC=-0.30; p=0.16) and (ICC=-0.19; p=0.37) respectively.

Conclusion: In axial SpA, the frequency of a positive 18-FNa PET (78.3%) was higher than the frequency of an ASAS positive MRI for inflammatory sacroiliitis (39.1%) and was also higher than the frequency of structural damages on CT-scan (39.1%). PET activity score had a good correlation with inflammatory sacroiliitis but not with structural lesion on CT-scan.


Disclosure: M. Raynal, None; O. remy, None; J. Melchior, None; I. Chary-Valckenaere, None; W. Ngueyon Sime, None; W. P. Maksymowych, None; R. G. Lambert, None; D. Loeuille, None.

To cite this abstract in AMA style:

Raynal M, remy O, Melchior J, Chary-Valckenaere I, Ngueyon Sime W, Maksymowych WP, Lambert RG, Loeuille D. Performance of 18fluoride Sodium Positron Emission Tomography with Computed Tomography to Assess Inflammatory and Structural Sacroiliitis Respectively on Magnetic Resonance Imaging and Computed Tomography in Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/performance-of-18fluoride-sodium-positron-emission-tomography-with-computed-tomography-to-assess-inflammatory-and-structural-sacroiliitis-respectively-on-magnetic-resonance-imaging-and-computed-tomogr/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/performance-of-18fluoride-sodium-positron-emission-tomography-with-computed-tomography-to-assess-inflammatory-and-structural-sacroiliitis-respectively-on-magnetic-resonance-imaging-and-computed-tomogr/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology